Shadi Kalantarian, MD
Cardiac Electrophysiology · East Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 5 carriers
- Offices
- 9
Offices
9 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
17 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kalantarian’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A145597 · Current
Licensed to practise in California · since 2016 · expires 2028-09-30 · Shahid Beheshti University of Medical Sciences.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$298,748
Medicare paid this office $298,748 for 683 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 237 | $73,103 | $157 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 112 | $48,160 | $430 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 135 | $28,591 | $201 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 83 | $23,926 | $184 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 79 | $21,291 | $184 |
See all 26 services
| Long return visit (40+ min) | 237 | $73,103 | $157 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 112 | $48,160 | $430 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 135 | $28,591 | $201 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 83 | $23,926 | $184 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 79 | $21,291 | $184 |
| New patient visit (60+ min) | 78 | $15,158 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $10,883 | $104 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $7,351 | $147 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $7,168 | $512 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 248 | $5,034 | $13 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 238 | $4,970 | $15 |
| Programming of dual lead pacemaker system | 27 | $4,023 | $74 |
| Programming of heart rhythm stimulation after drug infusion | 99 | $3,942 | $39 |
| External shock to heart to regulate heart beat | 36 | $3,591 | $95 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 122 | $3,234 | $22 |
| Long return visit (40+ min) | 23 | $2,980 | $130 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $2,897 | $241 |
| Return visit (30+ min) | 27 | $2,262 | $84 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 35 | $1,979 | $22 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 12 | $1,965 | $164 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 27 | $1,816 | $24 |
| Heart rhythm recording of continous external ekg over 8-15 days | 122 | $1,766 | $12 |
| Return visit (30+ min) | 12 | $1,476 | $123 |
| 3d radiographic procedure | 47 | $1,259 | $26 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 14 | $307 | $20 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 14 | $197 | $13 |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
683 Original Medicare patients in 2024. Average age 78 · Women 43% · Also on Medicaid 6% · Health risk score 1.28. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Atrial fibrillation 75% · Coronary heart disease 37% · Heart failure 31% · Diabetes 21% · Chronic kidney disease 21% · Cancer 17% · Depression 14% · COPD 10% · Stroke 8% · Dementia 6%.
The office billed $1,406,029, Medicare allowed $387,718 and paid $298,748; for 2,947 services of 60 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 683 | 2,947 | 78 | 1.28 | $1,406,029 | $298,748 |
| 2023 | 558 | 1,647 | 78 | 1.27 | $641,377 | $148,246 |
| 2022 | 100 | 227 | 80 | 1.33 | $69,513 | $19,300 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Long return visit (40+ min) | 194 | $57,489 | $161 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 87 | $21,106 | $243 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 66 | $8,631 | $79 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 61 | $7,246 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $7,240 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $6,421 | $149 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,913 | $447 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 196 | $3,904 | $14 |
| Programming of dual lead pacemaker system | 27 | $3,064 | $75 |
| Return visit (30+ min) | 17 | $1,783 | $105 |
| Return visit (30+ min) | 20 | $1,689 | $84 |
| Programming of heart rhythm stimulation after drug infusion | 69 | $1,622 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 53 | $1,356 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 28 | $1,259 | $21 |
| External shock to heart to regulate heart beat | 13 | $1,258 | $97 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 25 | $1,166 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 53 | $706 | $12 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 18 | $385 | $21 |
| Ultrasound of heart, follow-up | 12 | $265 | $22 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 12 | $250 | $21 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 18 | $160 | $9 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 12 | $148 | $12 |
2022: 4 services
| Long return visit (40+ min) | 54 | $9,421 | $165 |
| Return visit (30+ min) | 12 | $1,431 | $119 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 25 | $616 | $25 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 20 | $534 | $27 |
Drugs they prescribed that Part D paid
$535,022
Pharmacies billed $535,022 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,642) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,176 generic and 466 brand-name prescriptions · $535,022 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 227 | $256,357 | $1,129 |
| Xarelto | 83 | $115,691 | $1,394 |
| Jardiance | 57 | $61,110 | $1,072 |
| Entresto | 35 | $46,673 | $1,334 |
| Multaq | 15 | $14,369 | $958 |
See all 27 drugs
| Eliquis | 227 | $256,357 | $1,129 |
| Xarelto | 83 | $115,691 | $1,394 |
| Jardiance | 57 | $61,110 | $1,072 |
| Entresto | 35 | $46,673 | $1,334 |
| Multaq | 15 | $14,369 | $958 |
| Metoprolol | 176 | $3,663 | $21 |
| Atorvastatin | 154 | $2,167 | $14 |
| Valsartan | 27 | $1,815 | $67 |
| Dofetilide | 17 | $1,792 | $105 |
| Rosuvastatin | 57 | $1,540 | $27 |
| Amiodarone | 14 | $1,440 | $103 |
| Potassium Chloride | 41 | $1,321 | $32 |
| Carvedilol | 92 | $848 | $9 |
| Diltiazem 24hr Er (Cd) | 34 | $835 | $25 |
| Losartan | 42 | $598 | $14 |
| Amlodipine Besylate | 98 | $571 | $6 |
| Ezetimibe | 24 | $538 | $22 |
| Spironolactone | 62 | $515 | $8 |
| Digoxin | 27 | $353 | $13 |
| Diltiazem | 13 | $336 | $26 |
| Losartan-Hydrochlorothiazide | 30 | $290 | $10 |
| Furosemide | 45 | $289 | $6 |
| Metoprolol | 27 | $267 | $10 |
| Sotalol | 14 | $262 | $19 |
| Sotalol Af | 12 | $207 | $17 |
| Lisinopril | 17 | $114 | $7 |
| Nitroglycerin | 14 | $76 | $5 |
Year by year
| 2024 | 1,642 | 216 | 0% (0) | 28% | $535,022 |
| 2023 | 823 | 134 | 0% (0) | 25% | $259,740 |
| 2022 | 79 | 36 | 0% (0) | 27% | $19,467 |
| 2017 | 49 | 14 | None | None | $3,539 |
| 2016 | 15 | None | 0% (0) | None | $69 |
| 2015 | 72 | 28 | None | None | $11,229 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Eliquis | 100 | $111,788 | $1,118 |
| Xarelto | 50 | $70,670 | $1,413 |
| Entresto | 22 | $26,740 | $1,215 |
| Jardiance | 11 | $12,152 | $1,105 |
| Dofetilide | 14 | $7,314 | $522 |
| Metoprolol | 73 | $2,033 | $28 |
| Amiodarone | 14 | $1,698 | $121 |
| Atorvastatin | 107 | $1,503 | $14 |
| Valsartan | 15 | $1,480 | $99 |
| Diltiazem 24hr Er (Cd) | 18 | $1,312 | $73 |
| Rosuvastatin | 18 | $1,210 | $67 |
| Ezetimibe | 14 | $1,151 | $82 |
| Potassium Chloride | 17 | $654 | $38 |
| Diltiazem | 14 | $633 | $45 |
| Amlodipine Besylate | 51 | $573 | $11 |
| Digoxin | 21 | $456 | $22 |
| Losartan-Hydrochlorothiazide | 24 | $417 | $17 |
| Carvedilol | 28 | $414 | $15 |
| Simvastatin | 14 | $307 | $22 |
| Losartan | 16 | $190 | $12 |
| Furosemide | 12 | $82 | $7 |
2022: 1 drug
| Atorvastatin | 12 | $130 | $11 |
Money from drug and device companies
$755 in 2025
| 2025 | 3 | 8 | None | $755 |
| 2024 | 4 | 7 | $1,500 | $1,986 |
| 2023 | 6 | 9 | $1,500 | $2,647 |
| 2022 | 4 | 20 | None | $2,031 |
| 2021 | 2 | 17 | None | $1,642 |
| 2020 | 2 | 15 | None | $1,624 |
| 2019 | 3 | 35 | None | $4,739 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $353 | 5 payments
|
| Abbott Laboratories | Ensite | $238 | 2 payments
|
| Medtronic | Aurora Ev-Icd Mri Surescan | $164 | 1 payment
|
See all 8 published payments
| AtriCure | Meals · 2025-07-23 | Epi-Sense Guided Coagulation System With Visitrax | $164 |
| AtriCure | Meals · 2025-07-17 | Epi-Sense Guided Coagulation System With Visitrax | $37 |
| AtriCure | Meals · 2025-05-27 | Epi-Sense Guided Coagulation System With Visitrax | $106 |
| Medtronic | Meals · 2025-05-19 | Aurora Ev-Icd Mri Surescan | $164 |
| AtriCure | Meals · 2025-05-19 | Synergy Ablation System | $36 |
| AtriCure | Meals · 2025-05-19 | Synergy Ablation System | $11 |
| Abbott Laboratories | Meals · 2025-03-17 | Ensite | $214 |
| Abbott Laboratories | Meals · 2025-03-11 | Perclose Prostyle | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,986
| Medical Device Business Services | Carto 3 | $1,500 | 1 payment
|
| Biosense Webster | Qdot Micro Catheter | $215 | 4 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $149 | 1 payment
|
| Boston Scientific | Rhythmia Mapping System | $122 | 1 payment
|
2023: $2,647
| Medical Device Business Services | Carto 3 | $1,500 | 1 payment
|
| Abbott Laboratories | Ensite | $363 | 2 payments
|
| Biosense Webster | Qdot Micro Catheter | $296 | 3 payments
|
| Ablacon | None | $241 | 1 payment
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $150 | 1 payment
|
| Medtronic | Micra | $96 | 1 payment
|
2022: $2,031
| Abbott Laboratories | Ensite Precision | $703 | 7 payments
|
| Medical Device Business Services | Carto 3 | $650 | 2 payments
|
| Biosense Webster | Carto 3 | $401 | 9 payments
|
| Medtronic | Micra | $276 | 2 payments
|
2021: $1,642
| Medtronic | Micra | $1,251 | 9 payments
|
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $391 | 8 payments
|
2020: $1,624
| Medtronic Vascular | Azure | $1,599 | 14 payments
|
| Abbott Laboratories | Perclose Proglide Suture Mediated Closure System | $25 | 1 payment
|
2019: $4,739
| Medtronic Vascular | Micra | $3,262 | 22 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $1,380 | 12 payments
|
| Boston Scientific | General Therapies | $97 | 1 payment
|
Professional record
- NPI
- 1871906875
- Licence
- CA A145597California A145597: Current · expires 2028-09-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2014-06-06
- NPI last updated
- 2024-10-29
- NPI record certified
- 2024-10-29
This is when the NPI record was last certified, not a medical board exam.